Copyright
©The Author(s) 2023.
World J Med Genet. Jul 20, 2023; 11(3): 28-38
Published online Jul 20, 2023. doi: 10.5496/wjmg.v11.i3.28
Published online Jul 20, 2023. doi: 10.5496/wjmg.v11.i3.28
Autoimmune diseases | Pathogenesis | Genetics (SNP) | Therapy |
Systemic lupus erythematosus | Acute necrotizing vasculitis | IL-2 330/T (IL-2); IL-2 330/G (IL-2); rs2069763 (IL-2); rs6822844 G/T; (IL2-IL21) | Low dose IL-2, Rituximab |
Rheumatoid arthritis | Inflammatory synovitis | rs791588 (IL2RA); rs2281089 (IL2RA); rs2104286 (IL2RA) | Low dose IL-2, Infliximab |
Systemic sclerosis | Obliterative vasculopathy fibrosis | rs2069762A (IL-2); rs6822844T (IL2-IL21); rs6835457G (IL-2); rs907715T (IL-2); IL2-384-G (IL-2); rs11594656 (IL-2RA); rs2104286(IL-2); rs12722495 (IL-2) | Low dose IL-2, Basiliximab |
Multiple sclerosis | Inflammatory demyelination | rs2104286 (IL-2); rs11594656 (IL-2RA); rs35285258 (IL-2RB) | Tregs, MDSCs, IL-2 |
Sjogren syndrome | Salivary and lacrimal glands dysfunction | No data | Low dose IL-2 |
- Citation: Rafaqat S, Rafaqat S. Role of IL-2/IL-2 receptor in pathogenesis of autoimmune disorders: Genetic and therapeutic aspects. World J Med Genet 2023; 11(3): 28-38
- URL: https://www.wjgnet.com/2220-3184/full/v11/i3/28.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v11.i3.28